Real-Life Safety Profile of the 9-Valent HPV Vaccine Based on Data from the Puglia Region of Southern Italy
Human Papillomavirus (HPV) is responsible for epithelial lesions and cancers in both males and females. The latest licensed HPV vaccine is Gardasil-9<sup>®</sup>, a 9-valent HPV vaccine which is effective not only against the high-risk HPV types, but also against the ones responsible for...
Main Authors: | Antonio Di Lorenzo, Paola Berardi, Andrea Martinelli, Francesco Paolo Bianchi, Silvio Tafuri, Pasquale Stefanizzi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/3/419 |
Similar Items
-
Safety Profile of Recommended Vaccinations in Adolescents: Data from Surveillance of Adverse Events Following Immunization in Puglia (Italy), 2016–2020
by: Antonio Di Lorenzo, et al.
Published: (2021-11-01) -
Safety profile of MenB-FHBp vaccine among adolescents: data from surveillance of Adverse Events Following Immunization in Puglia (Italy), 2018–2020
by: Pasquale Stefanizzi, et al.
Published: (2022-01-01) -
Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia Region, 2014–19
by: Pasquale Stefanizzi, et al.
Published: (2022-01-01) -
Allergic adverse events following immunization: Data from post-marketing surveillance in Apulia region (South of Italy)
by: Pasquale Stefanizzi, et al.
Published: (2023-02-01) -
Immunogenicity and safety of BNT162b2 mRNA COVID-19 vaccine in a subject affected by Shapiro’s syndrome: A case report
by: Lorenza Moscara, et al.
Published: (2022-11-01)